Of all the millions of people who have tried weight-loss drugs such as Wegovy and Zepbound, nearly one in four people don’t respond to treatment. They lose little weight, or none at all, and see few ...
Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...
Matthew Herper covers medical innovation — both its promise and its perils. Specific changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs used to ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Novo Nordisk's new Wegovy GLP-1 pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections. CNBC spoke with five U.S.
An incredible one in 10 American adults are already taking GLP-1 drugs. Products like Wegovy, Ozempic, Zepbound and Mounjaro are now household names. And that number could just continue to rise as ...
Many people who use glucagon-like peptide-1 (GLP-1) weight loss drugs are reluctant to keep using their injections or pills indefinitely, especially after reaching their weight loss goals. But ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. This photo provided by Eli Lilly in April 2026 ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Food and Drug Administration has approved Foundayo, Eli Lilly’s new GLP-1 pill to treat ...
The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...
The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...
The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results